Fortitude Family Office’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.4K Buy
56
+2
+4% +$218 ﹤0.01% 849
2026
Q1
$4.99K Buy
54
+16
+42% +$1.61K ﹤0.01% 914
2025
Q4
$3.88K Buy
38
+5
+15% +$447 ﹤0.01% 908
2025
Q3
$2.06K Sell
33
-3
-8% -$163 ﹤0.01% 1206
2025
Q2
$1.87K Buy
+36
New +$1.61K ﹤0.01% 1234

Other funds holding GH

Fortitude Family Office's GH Position: Q2 2026 in Review

Fortitude Family Office increased its Guardant Health (GH) stake by 3.7% in Q2 2026, buying an estimated $218 and bringing the position to 56 shares worth $8.4K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Fortitude Family Office first reported a position in GH in Q2 2025 and has held it in 5 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Fortitude Family Office held 56 shares of Guardant Health worth $8.4K as of Q2 2026.
  • Fortitude Family Office bought 2 Guardant Health shares in Q2 2026, an estimated $218.
  • Guardant Health made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #849 holding.
  • Fortitude Family Office first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.